Findings from Kenya: Male circumcision reduces HPV infections

May 10, 2021
It’s well-established that male circumcision reduces the risk of human immunodeficiency virus (HIV) infection in men. A recent study from Kenya, published in Cancer Epidemiology, Biomarkers & Prevention, finds that male circumcision also reduces men’s risk of infection with human papillomavirus (HPV).

Researchers develop method for evaluating long-term COVID-19 vaccine efficacy

April 27, 2021
The large-scale deployment of effective vaccines is globally recognized as the best way to end the COVID-19 pandemic. However, the high efficacy reported for vaccines currently in use — like Pfizer and Moderna — is based on an average follow-up time of only about two months after the second dose. The question remains: Will people need booster vaccinations?

A single vaccine dose may offer protection to those who have had COVID-19

March 2, 2021
The results in a new preprint study from UNC-Chapel Hill suggest that those who have previously had COVID-19 gain a similar level of antibody protection from one dose of vaccine as those who have never had COVID-19 gain from two doses.

Study shows new machine learning method may lead to optimal cancer treatment decisions

December 4, 2020
Researchers at the University of North Carolina at Chapel Hill and North Carolina State University have developed a computational framework to generate evidence-based optimal cancer treatment decisions informed by a patient’s genomic biomarkers. The findings, which may aid in the development of precision cancer treatments, are published in the Journal of the American Statistical Association.

Study finds more physical activity, less TV equals more years cancer-free

October 28, 2020
Increasing physical activity and watching less TV may help people live more years cancer-free. Dr. Carmen Cuthbertson, a postdoctoral research fellow in the Department of Epidemiology, shared these findings in Cancer Epidemiology, Biomarkers & Prevention.

Groundbreaking study reveals genetic markers for Type 2 diabetes in East Asians

July 6, 2020
A recent study — the largest of its kind in any non-European population — demonstrates that while different populations of people share similar genetic predispositions for Type 2 diabetes, they also have some genetic variations that can alter their susceptibility to developing the disease.

Gillings researchers identify potential strategy for rapid scale-up of COVID-19 testing

June 29, 2020
Researchers at the Gillings School have identified a possible testing model for SARS-CoV-2 that could rapidly and efficiently screen 2 to 20 times as many people as an individual molecular-based test could.

Study in more than 165,000 participants supports connection between particulate matter air pollution and inflammation

January 21, 2020
A new study indicates that mid- to long-duration exposure to ambient particulate matter in air pollution is associated with increased inflammatory responses in diverse U.S. populations. This research supports an already established connection between exposure to particulate matter and an increased risk of cardiovascular disease.

UNC awarded $2.91 million to create new ultra-long-acting HIV drug delivery implant

December 2, 2019
Doctoral students Katie Mollan and Bonnie Shook-Sa, along with Dr. Michael Hudgens, are part of an investigative team that recently received a $2.91 million award from the Bill & Melinda Gates Foundation to create an ultra-long-acting implant for HIV drug delivery.

Pancreatic cancer tumor classification could optimize treatment choices

November 22, 2019
A study from the University of North Carolina's Lineberger Comprehensive Cancer Center could help predict resistance to treatments for pancreatic cancer — one of the deadliest cancer types.

...
3
4
5
1
2
6
7
8
9
...
RELATED PAGES
CONTACT INFORMATION
Visit our communications and marketing team page.
Contact sphcomm@unc.edu with any media inquiries or general questions.

Communications and Marketing Office
125 Rosenau Hall
CB #7400
135 Dauer Drive
Chapel Hill, NC 27599-7400